1. Home
  2. EYEN vs ONCY Comparison

EYEN vs ONCY Comparison

Compare EYEN & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • ONCY
  • Stock Information
  • Founded
  • EYEN 2014
  • ONCY 1998
  • Country
  • EYEN United States
  • ONCY Canada
  • Employees
  • EYEN N/A
  • ONCY N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • EYEN Health Care
  • ONCY Health Care
  • Exchange
  • EYEN Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • EYEN 38.2M
  • ONCY 103.8M
  • IPO Year
  • EYEN 2018
  • ONCY 1999
  • Fundamental
  • Price
  • EYEN $0.55
  • ONCY $1.19
  • Analyst Decision
  • EYEN Strong Buy
  • ONCY Strong Buy
  • Analyst Count
  • EYEN 2
  • ONCY 2
  • Target Price
  • EYEN $12.00
  • ONCY $4.00
  • AVG Volume (30 Days)
  • EYEN 879.0K
  • ONCY 903.7K
  • Earning Date
  • EYEN 11-11-2024
  • ONCY 11-05-2024
  • Dividend Yield
  • EYEN N/A
  • ONCY N/A
  • EPS Growth
  • EYEN N/A
  • ONCY N/A
  • EPS
  • EYEN N/A
  • ONCY N/A
  • Revenue
  • EYEN $31,405.00
  • ONCY N/A
  • Revenue This Year
  • EYEN $50,309.30
  • ONCY N/A
  • Revenue Next Year
  • EYEN $421.63
  • ONCY N/A
  • P/E Ratio
  • EYEN N/A
  • ONCY N/A
  • Revenue Growth
  • EYEN N/A
  • ONCY N/A
  • 52 Week Low
  • EYEN $0.37
  • ONCY $0.84
  • 52 Week High
  • EYEN $2.57
  • ONCY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 52.60
  • ONCY 52.51
  • Support Level
  • EYEN $0.52
  • ONCY $1.17
  • Resistance Level
  • EYEN $0.59
  • ONCY $1.28
  • Average True Range (ATR)
  • EYEN 0.05
  • ONCY 0.09
  • MACD
  • EYEN 0.01
  • ONCY -0.01
  • Stochastic Oscillator
  • EYEN 66.45
  • ONCY 28.00

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: